Daily BriefsMost Read

Most Read: Newmont Mining, Eoflow , Elite Material, Keisei Electric Railway Co, Medtronic Plc, Azure Minerals, Mini Kospi 200 Futures, Ecopro BM , KakaoBank , Hollysys Automation Technologies and more

In today’s briefing:

  • Newcrest/Newmont – More Selling on the NCM Means More Buying on NEM, And Settlement Logistics Matter
  • Medtronic’s M&A of Eoflow Timeline Postponed
  • Yuanta/​P-Shares Taiwan Div Plus ETF Rebalance Preview: In-The-Money; Turnover & Trade Remain High
  • Keisei Electric: Activists Arrive As Expected
  • EOFlow/Medtronic: Signs of Life
  • Gina Can’t “Liontown” SQM’s Bid For Azure
  • Key Points to Consider at This Stage Regarding the Year-End Ex-Dividend Play
  • Ecopro Innovation Is Selling Ecopro BM Shares
  • Increasing Probability of Kakao Corp Losing Its Controlling Shareholding of Kakao Bank
  • What To Make Of Hollysys’ Latest Offer


Newcrest/Newmont – More Selling on the NCM Means More Buying on NEM, And Settlement Logistics Matter

By Travis Lundy

  • Today saw 65mm shares of Newcrest Mining (NCM AU) print at the close and 85+mm shares crossed in blocks post-close. There was another 15mm shares traded in additional excess volume.
  • That suggests a certain lack of “risk taking” by passive managers, increasing today’s trade in NY. 
  • Furthermore, the settlement logistics appear to indicate an interesting trade to do 7 November (worth checking with your custodian/broker). 

Medtronic’s M&A of Eoflow Timeline Postponed

By Douglas Kim

  • On 25 October, Eoflow announced that the M&A of Eoflow by Medtronic has been postponed. 
  • The closing date for Eoflow’s stock transfer agreement with Medtronic has now been changed to 3 January 2024. 
  • Although we believe Medtronic will continue to pursue Eoflow, the M&A tender offer price could be lowered to about 26,000 won, which would be nearly 20% higher than current price.

Yuanta/​P-Shares Taiwan Div Plus ETF Rebalance Preview: In-The-Money; Turnover & Trade Remain High

By Brian Freitas

  • Using data from the close on 25 October, there could be 6 adds and 5 deletes to the Yuanta/​P-Shares Taiwan Dividend Plus ETF in December.
  • There will also be capping and funding flows that will lead to a one-way turnover of 19.5% and a one-way trade of US$1.39bn.
  • A long adds/ short deletes trade is up double digits over the last three weeks and there are a few trade adjustments based on the new rankings.

Keisei Electric: Activists Arrive As Expected

By Oshadhi Kumarasiri

  • Just as we suspected earlier in the year, there is now talk of an impending investor activism campaign targeting Keisei Electric Railway Co (9009 JP).
  • The activist is Palliser Capital, a multi-strategy fund based in London and run by former employees of Elliott Management, a company well-known for its activist campaigns in Japan.
  • Their proposal is simple and straightforward, requesting for a 35% reduction in Keisei Electric’s Oriental Land holding.

EOFlow/Medtronic: Signs of Life

By David Blennerhassett

  • When EOFlow (294090 KS) was suspended on the 11th October, and ceased global sales, either the Medtronic (MDT US) deal was (largely) toast; or it was a tactical move. 
  • I’m firmly in the latter camp. Insulet‘s lawsuit was expected. And completing the transaction enables the more financially and legally resource-rich MDT to become the party to the litigation.
  • The SPA between Jesse Kim and MDT was expected to complete on 25 October. That was not a hard date. It has now been pushed out to 3 January 2024. 

Gina Can’t “Liontown” SQM’s Bid For Azure

By David Blennerhassett

  • When lithium mining play Azure Minerals (AZS AU) was halted this week “regarding a potential change of control transaction“, Sociedad Quimica y Minera (SQM/B CI) was the obvious suitor.
  • This was confirmed this morning with a A$3.52/share Offer, a 44.3% premium to undisturbed, by way of a Scheme. A concurrent conditional off-market takeover at A$3.50/share is also present. 
  • $3.50 is locked in, no matter what. Gina may take her stake up to 19.9%, but it won’t affect the A$3.50 floor. But it may kickstart a competitive bidding situation. 

Key Points to Consider at This Stage Regarding the Year-End Ex-Dividend Play

By Sanghyun Park

  • The pivotal question now is the number of these companies that will effectively defer their year-end ex-dividend date to April next year.
  • The most reliable way to accurately confirm this would be to check how many of them will publicly announce the dividend reference date two weeks before the December year-end deadline.
  • This will serve as the most critical indicator in determining whether this year’s year-end flow trading event, the most significant in Korea, will recur.

Ecopro Innovation Is Selling Ecopro BM Shares

By Douglas Kim

  • On 26 October, it was announced that Ecopro Innovation is selling 160k shares of Ecopro BM shares (0.2% of outstanding shares), representing about 32 billion won.
  • Although the percentage of shares is small relative to its outstanding shares, this additional selling is likely to further negatively impact Ecopro BM’s shares in the near term.
  • Ecopro BM’s shares have seen a significant drop in price over the past few months, but its current P/E (87.3x in 2023) and EV/EBITDA (46.9x in 2023) multiples remain unattractive.

Increasing Probability of Kakao Corp Losing Its Controlling Shareholding of Kakao Bank

By Douglas Kim

  • In this insight, we discuss the increasing probability of Kakao Corp (035720 KS) losing its controlling shareholding of KakaoBank (323410 KS).
  • The FSS Chairman Lee Bok-Hyun emphasized that the FSS may punish Kakao Corp for a potential stock manipulation of S.M.Entertainment amid the M&A tender offer process earlier this year.
  • At this point, the higher probability event appears to be a combination of fine and Kakao Corp selling at least 10% of its stake in Kakao Bank to another company.

What To Make Of Hollysys’ Latest Offer

By David Blennerhassett

  • Hollysys (HOLI US), a leading automation control system solutions provider in China, has been subject to at least six indicative Offers since December 2020, ranging from US$15.47/share to $US$25/share. 
  • Yue Xu and Lei Fang, the co-chief operating officers of Hollysys, who previously tabled a NBIO of US$23.00/share in August 2021, have now pitched a US$25/share proposal.
  • What is different this time? >32% of the share registry has banded together to demand changes. That’s dramatically different vs previous Offers.

💡 Before it’s here, it’s on Smartkarma

Sign Up for Free

The Smartkarma Preview Pass is your entry to the Independent Investment Research Network

  • ✓ Unlimited Research Summaries
  • ✓ Personalised Alerts
  • ✓ Custom Watchlists
  • ✓ Company Analytics and News
  • ✓ Events & Webinars